XML 44 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Tables)
6 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Company’s matching contributions to the Plan
The following table reflects the Company’s contributions to the Plan during the three and six months ended March 31, 2018 and April 1, 2017:
 
Three months ended
 
Six months ended
(in thousands)
March 31, 2018
 
April 1, 2017
 
March 31, 2018
 
April 1, 2017
Cash
$
352

 
$
504

 
$
853

 
$
917

Accumulated other comprehensive income reflected on the Consolidated Balance Sheets
The following table reflects accumulated other comprehensive income reflected on the Consolidated Condensed Balance Sheets as of March 31, 2018 and September 30, 2017
 
As of
(in thousands)
March 31, 2018
 
September 30, 2017
Gain from foreign currency translation adjustments
$
10,014

 
$
2,422

Unrecognized actuarial loss on pension plan, net of tax
(1,761
)
 
(1,736
)
Unrealized gain on hedging
842

 
1,353

Accumulated other comprehensive income
$
9,095

 
$
2,039

Restricted stock and common stock granted
The following table reflects restricted stock and common stock granted during the three and six months ended March 31, 2018 and April 1, 2017:
 
Three months ended
 
Six months ended
(shares in thousands)
March 31, 2018
 
April 1, 2017
 
March 31, 2018
 
April 1, 2017
Time-based restricted stock
19

 
8

 
449

 
704

Relative TSR PSU

 
8

 
153

 
381

Special/Growth PSU

 

 
59

 

Common stock
8

 
11

 
17

 
25

Equity-based compensation in shares
27

 
27

 
678

 
1,110

Equity-based compensation expense
The following table reflects total equity-based compensation expense, which includes restricted stock, stock options and common stock, included in the Consolidated Condensed Statements of Operations during the three and six months ended March 31, 2018 and April 1, 2017
 
Three months ended
 
Six months ended
(in thousands)
March 31, 2018
 
April 1, 2017
 
March 31, 2018
 
April 1, 2017
Cost of sales
$
126

 
$
106

 
$
258

 
$
247

Selling, general and administrative
1,443

 
2,450

 
3,766

 
5,184

Research and development
653

 
522

 
1,307

 
1,249

Total equity-based compensation expense
$
2,222

 
$
3,078

 
$
5,331

 
$
6,680

The following table reflects equity-based compensation expense, by type of award, for the three and six months ended March 31, 2018 and April 1, 2017:  
 
Three months ended
 
Six months ended
(in thousands)
March 31, 2018
 
April 1, 2017
 
March 31, 2018
 
April 1, 2017
Time-based restricted stock
$
1,678

 
$
2,044

 
$
3,813

 
$
4,533

Relative TSR PSU
$
252

 
$
855

 
975

 
1,788

Special/Growth PSU
97

 

 
153

 

Common stock
195

 
179

 
390

 
359

Total equity-based compensation expense
$
2,222

 
$
3,078

 
$
5,331

 
$
6,680